Frame Support Study

Condition(s) studied

Investigational drug(s) / intervention(s)

Frame Access: FRAME™ provides a collaborative care platform that connects patients with evidence-based resources, education and support from a dedicated care team throughout their reproductive health care journey. More specifically, for patients exploring fertility treatment. Frame supplements the patient experience by providing patients with direct contact to board-certified fertility coaches and resources that can be accessed between appointments in a web-based application. Regular use of Frame's platform may help patients make lifestyle changes that can improve their fertility outcomes as well as boost their emotional health throughout the treatment process and reduce feelings of overwhelm and loneliness which can lead to patients dropping out of care.

Study summary

This is a randomized, controlled pilot study evaluating an intervention of non-significant risk. Potential subjects will be women who have completed an initial new patient consultation at one of the participating fertility clinics. Approximately 400 subjects will be enrolled from multiple fertility clinics.

Eligibility

Primary outcome measure(s)

• Fertility treatment initiation — This will be evaluated at the end of patient's study participation, approximately 6 months post enrollment.
  To observe whether the patient started fertility treatment.

Trial sites (1)

More Inception Fertility Research Institute, LLC trials in the USA

Other trials for the same condition